Eyenovia Inc (NASDAQ:EYEN)

3.60
BATS BZX Real-Time Price
As of 10:25am ET
 +0.09 / +2.56%
Today’s Change
1.11
Today|||52-Week Range
6.92
-19.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$91.1M

Company Description

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Contact Information

Eyenovia, Inc.
295 Madison Avenue
New York New York 10017
P:(917) 289-1117
Investor Relations:

Employees

Shareholders

Other institutional4.92%
Individual stakeholders38.33%
Mutual fund holders2.41%

Top Executives

Sean IanchulevPresident, CEO, Director & Chief Medical Officer
John P. GandolfoChief Financial Officer & Secretary
Luke ClausonVP-Engineering, Research & Development
Jennifer ClasbyVice President-Clinical Operations
Michael M. RoweVice President-Commercial